Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry María O. López-Oliva; Isabel Pérez-Flores; María Molina; María José Aladrén; Hernando Trujillo; Dolores Redondo-Pachón; Verónica López; Carme Facundo; Florentino Villanego; Marisa Rodríguez; Maria Carmen Ruiz; Paula Antón; Alba Rivas-Oural; Sheila Cabello; José Portolés; Lourdes de la Vara; Guadalupe Tabernero; Rosalía Valero; Cristina Galeano; Esperanza Moral; Ana Ventura; Armando Coca; Miguel Ángel Muñoz; Román Hernández-Gallego; Amir Shabaka; Gabriel Ledesma; Hanane Bouarich; María Ángeles Rodríguez; Lourdes Pérez Tamajón; Leónidas Cruzado; José Emilio Sánchez; Carlos Jiménez;

Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio Anna Vidal-Alabró; Helena Colom; Pere Fontova; Gema Cerezo; Edoardo Melilli; Nuria Montero; Ana Coloma; Anna Manonelles; Alex Favà; Josep M. Cruzado; Joan Torras; Josep M. Grinyó; Nuria Lloberas;

Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry Camilo Montero; Rodolfo Torres; Carlos Benavidez; Paola Garcia; Sandra Jimenez; Nancy Yomayusa; Diana Gayon; Jorge Perez; Diego Rosselli; Hector Restrepo; Carlos Alvarez-Moreno;